Huntington Bancshares slides as risk-off trading hits banks amid $100+ oil shock

Huntington Bancshares (HBAN) is down 3.6% today. Here is some analysis on what might have caused this price movement.

Analysis: The decline looks primarily tied to a broader risk-off session for equities and financials as oil surged above $100, stoking renewed inflation worries and uncertainty around the path of interest rates. In that backdrop, regional bank stocks can get hit on fears of slower growth, higher credit costs, and shifting rate-cut expectations.

Details:

Global markets weakened as crude oil jumped above $100 a barrel amid escalation in the Middle East conflict, pressuring U.S. equity futures and major indexes.

With energy prices rising, markets appeared to reduce expectations for 2026 rate cuts, a setup that can weigh on bank sentiment by increasing uncertainty around funding costs and loan demand.

Huntington is still in a post-deal integration phase after closing its Cadence Bank acquisition in early February 2026, which may amplify sensitivity to macro headlines as investors reassess execution and expense trajectories.

Recent strategic actions—such as shifting parts of its wealth offering to a third-party program partner and providing longer-dated (2027) targets—have kept attention on longer-term earnings power, but they did not offset today’s macro-driven selling pressure.

Sources:

The Guardian, MarketScreener, The Motley Fool

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$HBAN Insider Trading Activity

$HBAN insiders have traded $HBAN stock on the open market 15 times in the past 6 months. Of those trades, 6 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $HBAN stock by insiders over the last 6 months:

HELGA HOUSTON (Senior Exec. V. P.) sold 64,587 shares for an estimated $993,348
MARCY C HINGST (SEVP and General Counsel) has made 0 purchases and 2 sales selling 19,248 shares for an estimated $331,386.
BRENDAN A LAWLOR (Executive VP and CCO) has made 0 purchases and 2 sales selling 17,454 shares for an estimated $330,425.
JAMES D III ROLLINS has made 4 purchases buying 12,288 shares for an estimated $257,366 and 0 sales.
GARY TORGOW purchased 14,200 shares for an estimated $252,901
AMIT DHINGRA (Chief Enterprise Pmts Officer) sold 10,000 shares for an estimated $185,000
BRANTLEY J STANDRIDGE (Senior Exec. V.P.) sold 5,830 shares for an estimated $111,557
JOHN C INGLIS purchased 6,506 shares for an estimated $99,541
KENDALL A KOWALSKI (Chief Information Officer) has made 0 purchases and 2 sales selling 4,028 shares for an estimated $71,919.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$HBAN Hedge Fund Activity

We have seen 576 institutional investors add shares of $HBAN stock to their portfolio, and 474 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

WELLINGTON MANAGEMENT GROUP LLP added 68,478,435 shares (+4265.5%) to their portfolio in Q4 2025, for an estimated $1,188,100,847
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 39,582,328 shares (-74.9%) from their portfolio in Q4 2025, for an estimated $686,753,390
PRICE T ROWE ASSOCIATES INC /MD/ removed 20,387,914 shares (-32.1%) from their portfolio in Q4 2025, for an estimated $353,730,307
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 14,440,109 shares (+44.7%) to their portfolio in Q4 2025, for an estimated $250,535,891
VANGUARD GROUP INC added 14,338,222 shares (+8.1%) to their portfolio in Q4 2025, for an estimated $248,768,151
CITADEL ADVISORS LLC removed 13,766,463 shares (-60.6%) from their portfolio in Q4 2025, for an estimated $238,848,133
FEDERATED HERMES, INC. removed 8,164,830 shares (-38.3%) from their portfolio in Q4 2025, for an estimated $141,659,800

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$HBAN Congressional Stock Trading

Members of Congress have traded $HBAN stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $HBAN stock by members of Congress over the last 6 months:

SENATOR TINA SMITH sold up to $250,000 on 11/21.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$HBAN Analyst Ratings

Wall Street analysts have issued reports on $HBAN in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

RBC Capital issued a "Outperform" rating on 12/19/2025
Piper Sandler issued a "Underweight" rating on 12/10/2025
Evercore ISI Group issued a "Outperform" rating on 10/21/2025
TD Cowen issued a "Buy" rating on 10/20/2025
Truist Securities issued a "Buy" rating on 09/12/2025

To track analyst ratings and price targets for $HBAN, check out Quiver Quantitative's $HBAN forecast page.

$HBAN Price Targets

Multiple analysts have issued price targets for $HBAN recently. We have seen 11 analysts offer price targets for $HBAN in the last 6 months, with a median target of $20.0.

Here are some recent targets:

Manan Gosalia from Morgan Stanley set a target price of $23.0 on 03/02/2026
Vivek Juneja from JP Morgan set a target price of $21.0 on 02/09/2026
Brian Foran from Truist Securities set a target price of $21.0 on 01/26/2026
David Konrad from Keefe, Bruyette & Woods set a target price of $19.5 on 01/23/2026
Jason Goldberg from Barclays set a target price of $20.0 on 01/05/2026
Jon G. Arfstrom from RBC Capital set a target price of $20.0 on 12/19/2025
Scott Siefers from Piper Sandler set a target price of $16.0 on 12/10/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.